Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020
Corporate Participants:
Bruce Voss — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Analysts:
Jason McCarthy — Maxim Group — Analyst
Sally Yanchus — Brookline Capital Markets — Analyst
____
To read the full earnings call transcript, click here.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
Listen On
